Liver and Biliary Pathology Practice Questions

Q: Histological scoring of chronic hepatitis does not include which of the following?

Cholestasis. In chronic hepatitis, histological assessment is standardized using scoring systems like the **METAVIR** or **Knodell (Histological Activity Index)** systems. These systems evaluate two distinct parameters: **Grade** (degree of necro-inflammatory activity) and **Stage** (extent of fibrosis) [1]. **Why Cholestasis is the Correct Answer:** Cholestasis refers to the impairment of bile flow and is a feature of obstructive jaundice or primary biliary diseases (like PBC or PSC). While it may occur in acute hepatitis or end-stage cirrhosis, it is **not** a component of the standardized scoring systems used to assess the severity or progression of chronic viral hepatitis (HBV/HCV). **Analysis of Incorrect Options:** * **Periportal Inflammation (Interface Hepatitis):** This is a key component of the **Grade**. It describes the extension of inflammation from the portal tract into the surrounding parenchyma ("piecemeal necrosis"). * **Bridging Necrosis:** This represents severe necro-inflammatory activity where areas of necrosis connect portal-to-portal or portal-to-central veins [1]. It is a major factor in determining the **Grade**. * **Portal Fibrosis:** This defines the **Stage** of the disease. Scoring tracks the progression from simple portal fibrosis to bridging fibrosis and, ultimately, cirrhosis [1]. **NEET-PG High-Yield Pearls:** * **METAVIR System:** Specifically designed for Hepatitis C. * **Activity (A):** A0 (none) to A3 (severe). * **Fibrosis (F):** F0 (none) to F4 (cirrhosis). * **Ground Glass Hepatocytes:** Characteristic of Chronic Hepatitis B (due to HBsAg accumulation in the ER) [1]. * **Lymphoid Aggregates/Follicles:** Highly suggestive of Chronic Hepatitis C [1]. * **Interface Hepatitis:** The hallmark of "active" chronic hepatitis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-844.

Q: What is the most common liver cell tumor found in individuals using oral contraceptive pills?

Liver cell adenoma. **Explanation:** **Liver cell adenoma (Hepatocellular adenoma)** is a benign neoplasm of hepatocytes. Its development is strongly associated with the use of **oral contraceptive pills (OCPs)** containing estrogen [1]. The risk is proportional to the duration of use and the hormone dosage. Estrogen promotes the proliferation of hepatocytes, and cessation of OCPs often leads to the regression of these tumors [1]. **Analysis of Options:** * **Hepatocellular carcinoma (HCC):** While OCPs have been studied for potential links to HCC, the primary risk factors remain Hepatitis B/C, cirrhosis, and aflatoxin. HCC is a malignant tumor, whereas OCP-related lesions are typically benign. * **Bile duct adenoma:** These are small, benign tumors derived from biliary epithelium, not hepatocytes. They are usually incidental findings and have no established association with OCP use. * **Focal nodular hyperplasia (FNH):** FNH is a regenerative response to a pre-existing vascular malformation (characterized by a "central stellate scar"). While it is more common in females, it is **not** caused by OCPs, though OCPs may slightly increase the size of an existing FNH. **High-Yield Clinical Pearls for NEET-PG:** * **Complication:** The most feared complication of liver cell adenoma is **spontaneous rupture and intraperitoneal hemorrhage**, especially during pregnancy. * **Molecular Subtypes:** *HNF1-α inactivated* (lowest risk), *β-catenin activated* (highest risk of malignant transformation to HCC), and *Inflammatory* (most common) [1]. * **Management:** Large adenomas (>5 cm) or those with β-catenin mutations require surgical resection due to the risk of rupture or malignancy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 874.

Q: Oral contraceptive agents typically cause which of the following in the liver?

Cholestasis without portal inflammation. **Explanation:** The correct answer is **Cholestasis without portal inflammation (Option B)**. Oral Contraceptive Pills (OCPs) contain synthetic estrogens and progestins that can interfere with the transport of bile acids across the canalicular membrane [1]. This leads to **bland cholestasis**, characterized by the presence of bile plugs within dilated canaliculi and bilirubin staining of hepatocytes [1]. Crucially, this occurs **without** significant hepatocyte necrosis or portal tract inflammation, distinguishing it from viral or drug-induced hepatitis. **Analysis of Incorrect Options:** * **A. Microvesicular fatty infiltration:** This is classically associated with Reye’s syndrome, Acute Fatty Liver of Pregnancy (AFLP), and Valproate toxicity, not OCP use. * **C. Portal inflammation:** OCP-induced liver injury is "bland," meaning it lacks the inflammatory infiltrate (lymphocytes/neutrophils) typically seen in viral hepatitis or primary biliary cholangitis. * **D. Perivenular fibrosis:** This is a hallmark of alcoholic liver disease (steatohepatitis) and is not a feature of OCP-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **OCPs and Tumors:** OCP use is the most significant risk factor for **Hepatic Adenoma**. These tumors carry a risk of rupture and intraperitoneal hemorrhage, especially during pregnancy. * **Vascular Complications:** OCPs are prothrombotic and are a known risk factor for **Budd-Chiari Syndrome** (hepatic vein thrombosis). * **Gallstones:** Estrogen increases cholesterol secretion into bile (lithogenic bile), increasing the incidence of cholelithiasis in OCP users. * **Dubin-Johnson Syndrome:** OCPs can exacerbate jaundice in patients with underlying Dubin-Johnson or Rotor syndrome due to impaired bilirubin excretion [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 860-874.

Question 1

Histological scoring of chronic hepatitis does not include which of the following?

Accepted Answer

Cholestasis

Answer

Periportal inflammation

Answer

Portal fibrosis

Answer

Bridging necrosis

Question 2

A 60-year-old male with a known history of cirrhosis of the liver presents with elevated Alpha-fetoprotein levels and hepatomegaly 3 cm below the costal margin. Ultrasound reveals lesions in the right lobe of the liver. What is the most probable diagnosis?

Accepted Answer

Hepatocellular carcinoma

Answer

Focal nodular hyperplasia

Answer

Hepatic adenoma

Answer

Metastasis

Question 3

Acute liver injury associated with hepatitis B virus is due to which mechanism?

Accepted Answer

Sensitized cytolytic T-cells

Answer

Direct cytopathic effect of the virus

Answer

Immune-complex mediated tissue damage

Answer

Vasculitis

Question 4

All of the following simulate chronic hepatitis except?

Accepted Answer

HAV

Answer

HBV

Answer

Haemochromatosis

Answer

Wilson's disease

Question 5

What is the most common liver cell tumor found in individuals using oral contraceptive pills?

Accepted Answer

Liver cell adenoma

Answer

Hepatocellular carcinoma (HCC)

Answer

Bile duct adenoma

Answer

Focal nodular hyperplasia (FNH)

Question 6

Which of the following is the most common cause of pre-sinusoidal intrahepatic portal hypertension?

Accepted Answer

Schistosomiasis

Answer

Cirrhosis

Answer

Sarcoidosis

Answer

Graft-versus-host disease

Question 7

Gallstones in sickle cell anemia are primarily composed of which substance?

Accepted Answer

Bilirubin

Answer

Cholesterol

Answer

Calcium carbonate

Answer

None of the above

Question 8

Hepatocellular carcinoma is caused by all of the following except?

Accepted Answer

Exposure to industrial dyes

Answer

Hepatitis B

Answer

Primary Biliary Cirrhosis

Answer

Chronic alcohol consumption

Question 9

Oral contraceptive agents typically cause which of the following in the liver?

Accepted Answer

Cholestasis without portal inflammation

Answer

Microvesicular fatty infiltration

Answer

Portal inflammation

Answer

Perivenular fibrosis in portal circulation

Question 10

A 51-year-old man presents with a palpable, nodular liver and symptoms of chronic illness. Laboratory tests reveal positive anti-HCV antibodies and negative HBsAg and HBcAg. A liver biopsy shows chronic hepatitis with severe activity and fibrosis. Despite a 6-month course of interferon, his condition deteriorates, necessitating an orthotopic liver transplantation. One year post-transplantation, he develops elevated transaminase and bilirubin levels. To minimize chronic rejection injury to hepatic endothelial cells, which component of the immune response should immunosuppressive therapy primarily target?

Accepted Answer

T-lymphocyte activity

Answer

Autoantibody production

Answer

Complement protein synthesis

Answer

HLA antigen expression

Liver and Biliary Pathology — MCQs

Liver and Biliary Pathology — MCQs

On this page

Practice by Chapter

Want unlimited practice?